Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Ross Robert W., Chief Executive Officer. Insider active across 1 company, notably Surface Oncology, Inc.. Cumulatively, 5 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €205k. History available since 21 July 2021. The latest transaction was filed on 1 August 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
ROSS ROBERT W. is the Chief Executive Officer of Surface Oncology, Inc. He leads the company's operations and strategy, focusing on innovation and research in the oncology field. His leadership is essential for the development of new therapies.